DrugSafety Navigator

Drug Safety Navigator provides global pharmacovigilance support such as case management, signal detection, & benefit risk assessments.

[DrugSafety Navigator @DrugSafetyNavig]

Check out our newest blog:

Pharmacovigilance Inspection Readiness -- How to Nail your Upcoming Performance

https://t.co/3EoKPnoVZZ

[DrugSafety Navigator @DrugSafetyNavig]

What do the Regulatory Agencies know about you? How does that impact your inspection readiness? Check out our latest blog for answers!

https://t.co/3rzGJRWvyU

[DrugSafety Navigator @DrugSafetyNavig]

There are big new advancements for Expanded Access Programs. What does that mean for you? We got you covered.

https://t.co/P2yvbBLInp

[DrugSafety Navigator @DrugSafetyNavig]

Happy Holidays from the DSN Team!

[DrugSafety Navigator @DrugSafetyNavig]

We are at the #FDA #EAP conference learning about exciting developments and stakeholder collaborations to expedite products to patients and leveraging the data to improve product safety! #eaprotocols

[DrugSafety Navigator @DrugSafetyNavig]

New blog on regulation changes from the Foresight #Argus User Group Convention we attended!

Winter is Coming, as well as New Regulations: Are You Ready?

https://t.co/3EoKPnoVZZ

@OracleHealthSci

[DrugSafety Navigator @DrugSafetyNavig]

Our leadership team is excited to register for the @reaganudall - Leveraging Real-World Treatment Experience from EA Protocols Conference on November 19th! Looking forward to learning more about the Expanded Access Program with @WEP_Clinical

[DrugSafety Navigator @DrugSafetyNavig]

We want to thank the leaders of @PIPAtweet for the hospitality at the PIPA Conference at the @LEGOLANDWindsor earlier this month! We learned a lot about the potential effects of #Brexit on PV, met some inspiring professionals, and caught up with our friends over at @pharmasol !

[DrugSafety Navigator @DrugSafetyNavig]

Read our latest blog entry on the importance of Signal Safety Detection! https://t.co/NWmMl2uWjX

[DrugSafety Navigator @DrugSafetyNavig]

DSN is growing! Welcome industry veteran Joseph Knight-McKenna to the role of Director of Quality & Compliance. Joe joins us from Quintiles (new IQVIA). Welcome Joe!

[DrugSafety Navigator @DrugSafetyNavig]

Clinical trials test how Amazon’s Alexa can fit into healthcare https://t.co/hRKlj80uvo

[DrugSafety Navigator @DrugSafetyNavig]

Drug Safety Navigator is proud to announce our re-designed website, which you can check out at: https://t.co/qlzlplvHO3

Let us know what you think!

[pharmalot @pharmalot]

Pharmalot.. Pharmalittle... Good Morning...lots of headlines & coffee are served..https://t.co/x3rSIih6qn #pharma $NVS $BMY $SRPT $AMGN $AGN

[DrugSafety Navigator @DrugSafetyNavig]

Would Washington’s FDA Fix Cure the Patients or the Drug Industry? https://t.co/NEPum1w6hW via @MoneylifeIndia

[DrugSafety Navigator @DrugSafetyNavig]

Fentanyl, carfentanil prompt higher naloxone dosage | Behavioral Healthcare Magazine https://t.co/75lM8BtZD7

[DrugSafety Navigator @DrugSafetyNavig]

InFocus: Rethinking the Use of Fluoroquinolones : Emergency Medicine News https://t.co/2ZLBqciKk0

[DrugSafety Navigator @DrugSafetyNavig]

Bleak future for Hanmi’s new lung cancer drug amid safety concernsKoreaHerald https://t.co/ppKg8fhZRY

[DrugSafety Navigator @DrugSafetyNavig]

Johnson & Johnson hid faulty device concerns during key Xarelto study: BMJ https://t.co/JG17noThY3

[DrugSafety Navigator @DrugSafetyNavig]

Acetaminophen, the leading cause of liver damage: Health Canada adds new warning labels https://t.co/QLmwD8gcRq

[DrugSafety Navigator @DrugSafetyNavig]

The Danger in Taking Prescribed Medications | Patient Advice | US News https://t.co/7hOeV5SgHQ